News Detail
Ahmedabad, 31 Jan 2024: Zydus Lifesciences Ltd’s shares were up by 1.19 per cent after it launched the advanced prostate cancer drug Rexigo in India. This drug works by suppressing testosterone to manage prostate cancer.
Rexigo is priced ₹......
View Details
Source : The Hindu BusinessLine
rexigo
relugolix
adt
india
ahmedabad zydus lifesciences ltd
Health news
Related News
- NPPA asks retailers, dealers and online pharmacies to ensure compliance of Para 24 and 25 of DPCO, 2013 (11-02-2025)
- Kerala: 12 establishments caught selling fake cosmetics, including soaps and creams, with harmful chemicals (11-02-2025)
- EMA establishes regular procedure for scientific advice on certain high-risk medical devices (11-02-2025)
- Goyal urges the pharmaceutical industry to expose those engaged in sale of counterfeit products (11-02-2025)
- WHO identifies research priorities for boosting fight against antimicrobial resistance (11-02-2025)
- Supreme Court Calls on State Officials to Address Misleading Drug Advertisements (10-02-2025)
- Cases will be initiated immediately against individuals involved in sale of intoxicants and adulteration of drugs (10-02-2025)
- An index to gauge states for drug enforcement, improve drug quality (10-02-2025)
- China's health regulator defends quality of local generic drugs (10-02-2025)
- DGFT amends standard input output norms for erythromycin stearate tablets (10-02-2025)